24-month outcomes associated with belimumab in patients with systemic lupus erythematosus in clinical practice settings.
24-month outcomes associated with belimumab in patients with systemic lupus erythematosus in clinical practice settings.
- 2014
Medicine/Rheumatology
Poster presented at
Medicine/Rheumatology
Poster presented at